Original document(15 pages)  中文版
    The invention relates to a Laxi mouse disintegration tablet for treating cardiovascular disease and relative production. Wherein, said drug is mouse disintegration tablet, formed by Laxi, stuff, disintegrator, corrective, lubricant, and flow agent, via wet method or compression, while its disintegration time is 30-55s, and it uses deionized water as exsolution medium, while the exsolution rate at 30mins is 70-80%. The invention can be quickly absorbed, with simple process.
Application Number
申请号		 200610095133 Application Date
申请日		 2006.09.16
Title 名称 Lacidipine tablets disintegrating in oral cavity and process for producing same
Publication Number
公开号		 1923182 Publication Date
公开日		 2007.03.07
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/20;A61K31/4422;A61P9/12
Applicant(s) Name
申请人		 Wei Yumeng
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 xiahong
More information 更  多  信  息


 Related patents information
Method for preparing carrier of hollow microsphere for medication in use for treating gastrointestinal tract
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.